ID22730A - Derivatif-derivatif anti kejang isokuinoil-benzamida - Google Patents

Derivatif-derivatif anti kejang isokuinoil-benzamida

Info

Publication number
ID22730A
ID22730A IDW991041D ID991041D ID22730A ID 22730 A ID22730 A ID 22730A ID W991041 D IDW991041 D ID W991041D ID 991041 D ID991041 D ID 991041D ID 22730 A ID22730 A ID 22730A
Authority
ID
Indonesia
Prior art keywords
quinoil
benzamida
derivatives
Prior art date
Application number
IDW991041D
Other languages
English (en)
Indonesian (id)
Inventor
John David Dr Harling
Barry Sidney Dr Orlek
Mervyn Dr Thomson
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9705620.4A external-priority patent/GB9705620D0/en
Priority claimed from GBGB9726660.5A external-priority patent/GB9726660D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of ID22730A publication Critical patent/ID22730A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Addiction (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
IDW991041D 1997-03-18 1998-03-16 Derivatif-derivatif anti kejang isokuinoil-benzamida ID22730A (id)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9705620.4A GB9705620D0 (en) 1997-03-18 1997-03-18 Novel compounds
GBGB9726660.5A GB9726660D0 (en) 1997-12-17 1997-12-17 Novel compounds

Publications (1)

Publication Number Publication Date
ID22730A true ID22730A (id) 1999-12-09

Family

ID=26311216

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW991041D ID22730A (id) 1997-03-18 1998-03-16 Derivatif-derivatif anti kejang isokuinoil-benzamida

Country Status (26)

Country Link
US (1) US6277861B1 (fr)
EP (1) EP0971897A1 (fr)
JP (1) JP2001516357A (fr)
KR (1) KR20000076343A (fr)
CN (1) CN1255917A (fr)
AP (1) AP9901635A0 (fr)
AR (1) AR012078A1 (fr)
AU (1) AU732162B2 (fr)
BG (1) BG103807A (fr)
BR (1) BR9809048A (fr)
CA (1) CA2283682A1 (fr)
CO (1) CO4950554A1 (fr)
DZ (1) DZ2446A1 (fr)
EA (1) EA199900836A1 (fr)
ID (1) ID22730A (fr)
IL (1) IL131958A0 (fr)
MA (1) MA24499A1 (fr)
NO (1) NO313753B1 (fr)
NZ (1) NZ337579A (fr)
OA (1) OA11390A (fr)
PE (1) PE62199A1 (fr)
PL (1) PL335675A1 (fr)
SK (1) SK126799A3 (fr)
TR (1) TR199902282T2 (fr)
TW (1) TW509679B (fr)
WO (1) WO1998041507A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999016752A1 (fr) * 1997-09-30 1999-04-08 Molecular Designs International, Inc. AGONISTES DE β3-ADRENORECEPTEURS, COMPOSITIONS D'AGONISTES ET PROCEDES D'UTILISATION
GB9817424D0 (en) * 1998-08-11 1998-10-07 Smithkline Beecham Plc Novel compounds
GB9915589D0 (en) 1999-07-02 1999-09-01 Smithkline Beecham Plc Novel compounds
US6593341B2 (en) 2001-03-29 2003-07-15 Molecular Design International, Inc. β3-adrenoreceptor agonists, agonist compositions and methods of making and using the same
US6596734B1 (en) 2002-10-11 2003-07-22 Molecular Design International, Inc. Tetrahydroisoquinoline compounds for use as β3-adrenoreceptor agonists
CN109608325A (zh) * 2018-12-27 2019-04-12 先尼科化工（上海）有限公司 一种卤代苯甲酸衍生物的工业化合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4022900A (en) * 1970-09-09 1977-05-10 Marion Laboratories, Inc. Compositions containing 1,2,3,4-tetrahydroisoquinolines used as hypotensive agents
ES2036213T3 (es) * 1986-10-28 1993-05-16 Smith Kline & French Laboratories Limited Procedimiento para preparar derivados tetrahidroisoquinolin-1-ilicos de acidos carboxilicos.
GB8807922D0 (en) * 1988-04-05 1988-05-05 Fujisawa Pharmaceutical Co Isoquinoline compound & process for preparation thereof
US4883593A (en) * 1988-10-27 1989-11-28 Bend Research, Inc. Ultrathin-skinned asymmetric membranes by immiscible solvents treatment
GB9112721D0 (en) * 1991-06-13 1991-07-31 Smithkline Beecham Plc Novel treatment
EP0906283A1 (fr) * 1996-06-17 1999-04-07 Smithkline Beecham Plc Derives substitues du benzamide et leur utilisation comme anticonvulsivants

Also Published As

Publication number Publication date
WO1998041507A1 (fr) 1998-09-24
BG103807A (bg) 2001-05-31
CN1255917A (zh) 2000-06-07
DZ2446A1 (fr) 2003-01-11
IL131958A0 (en) 2001-03-19
CO4950554A1 (es) 2000-09-01
BR9809048A (pt) 2000-08-01
NO994504L (no) 1999-09-17
NO313753B1 (no) 2002-11-25
EA199900836A1 (ru) 2000-04-24
SK126799A3 (en) 2000-05-16
MA24499A1 (fr) 1998-10-01
AP9901635A0 (en) 1999-09-30
OA11390A (en) 2004-04-14
AU732162B2 (en) 2001-04-12
TW509679B (en) 2002-11-11
NO994504D0 (no) 1999-09-17
NZ337579A (en) 2001-04-27
AU6412798A (en) 1998-10-12
PE62199A1 (es) 1999-09-10
TR199902282T2 (en) 2000-07-21
US6277861B1 (en) 2001-08-21
PL335675A1 (en) 2000-05-08
CA2283682A1 (fr) 1998-09-24
AR012078A1 (es) 2000-09-27
EP0971897A1 (fr) 2000-01-19
KR20000076343A (ko) 2000-12-26
JP2001516357A (ja) 2001-09-25

Similar Documents

Publication Publication Date Title
ATE260243T1 (de) N-aroylphenylalaninderivate
ATE235220T1 (de) Resorcinderivate
ID22781A (id) Turunan-turunan nikotinamida
DE69817186D1 (de) Diaminorhodamin-derivate
ID23015A (id) Senyawa-senyawa anti radang
ATE323682T1 (de) Aryl-pyrimidin-derivate
ATE261942T1 (de) 6-phenylpyridinderivate
PT915088E (pt) Derivados de d-prolina
DE59508427D1 (de) 3-aryl-4-hydroxy-delta 3 -dihydrothiophenon-derivate
IS1902B (is) Nýjar 19-nor-pregnene afleiður
NO981946D0 (no) Imidazoquinazolin-derivater
ATE255098T1 (de) Substituierte chromanderivate
DE69732576D1 (de) Tetrahydrobenzindolon-derivate
PT1003719E (pt) Derivados microbicidas de n-sulfonil-glicinalquiniloxifenemetilamida
DE69841086D1 (de) 5-Deoxy-Cytidin-Derivate
PT1027362E (pt) Derivados de cetolidos 2-halogeno-6-o-substituidos
ATE255099T1 (de) Substituierte chromanderivate
EE9900182A (et) 2-metoksüfenüülpiperasiini derivaadid
DK0966437T3 (da) 5-Aroylnaphthalenderivater
ATE292632T1 (de) Cis-disubstituierte aminocycloalkyl-pyrrolidin- derivate
DE69828780D1 (de) Amidinocamptpthecin-derivate
NO981495D0 (no) Phenoxymetylpiperidin-derivater
DK1015447T3 (da) Piperidinylmethyloxazolidinonderivat
FI965181L (fi) Polyalkoholi-peptidijohdannaiset
ATA73396A (de) 3-methylimino-3-cephemderivate 3-methylimino-3-cephemderivate